Quality criteria for pediatric oncology centers: A systematic literature review.


Journal

Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310

Informations de publication

Date de publication:
09 2023
Historique:
revised: 20 07 2023
received: 21 03 2023
accepted: 03 08 2023
medline: 9 10 2023
pubmed: 16 8 2023
entrez: 16 8 2023
Statut: ppublish

Résumé

Survival of children and adolescents diagnosed with cancer improved over the last decades due to better diagnostics, treatment, and supportive care. Quality criteria that measure, compare, and make the quality of care of individual pediatric oncology centers more transparent are heterogeneous and inconsistent. With this systematic review, we aimed to summarize existing quality criteria for pediatric oncology centers in countries with highly developed health-care systems. We searched three databases for publications, and websites for guidelines about quality criteria for pediatric oncology centers in February 2022. We considered all types of publications except expert opinions. We excluded publications not focusing on highly developed health-care systems, addressing the certification of professionals, or focusing on subspecialties (e.g., pediatric neuro-oncology). We discarded quality criteria if they were too specific (e.g., for a specific treatment center), too broad (e.g., national 5-year overall survival), or if the aspect was covered by standardized clinical procedures or at the national level. We grouped the identified criteria thematically. We identified 18 publications and guideline documents with 530 criteria, of which 201 fulfilled the inclusion criteria. The combination of similar criteria resulted in 90 overarching criteria, which we assigned to the following categories: facilities and networks, multidisciplinary team and other experts, supportive care, treatment, long-term care, and volume and numbers. Our results provide a comprehensive overview of existing quality criteria for pediatric oncology in countries with highly developed health-care systems. These criteria can serve as a basis to develop national quality criteria in pediatric oncology.

Identifiants

pubmed: 37584279
doi: 10.1002/cam4.6452
pmc: PMC10557895
doi:

Types de publication

Systematic Review Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18999-19012

Informations de copyright

© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Références

J Pediatr Oncol Nurs. 2008 Jul-Aug;25(4):208-12
pubmed: 18539908
J Crit Care. 2011 Feb;26(1):103.e9-12
pubmed: 20619598
Pediatrics. 2012 Jul;130(1):e201-10
pubmed: 22711718
J Patient Saf. 2020 Sep;16(3):e120-e125
pubmed: 27314203
QRB Qual Rev Bull. 1986 Mar;12(3):99-108
pubmed: 3085044
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Apr;63(4):475-481
pubmed: 32161982
Pediatr Blood Cancer. 2019 Feb;66(2):e27504
pubmed: 30318786
Cancer Med. 2020 Oct;9(19):6984-6995
pubmed: 32777172
Pediatr Blood Cancer. 2012 Feb;58(2):303-5
pubmed: 21509930
Anticancer Res. 2011 Feb;31(2):661-4
pubmed: 21378352
Ann Oncol. 2013 Jul;24(7):1749-1753
pubmed: 23378538
Eur J Cancer. 2015 Jun;51(9):1064-79
pubmed: 25899984
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Pediatr Blood Cancer. 2016 Jan;63(1):112-7
pubmed: 26292080
Cancer Med. 2023 Sep;12(18):18999-19012
pubmed: 37584279
Br J Haematol. 2020 May;189(4):607-624
pubmed: 32159231
Pediatr Blood Cancer. 2013 Aug;60(8):1299-306
pubmed: 23417978
J Pediatr Hematol Oncol. 2017 Mar;39(2):90-96
pubmed: 27467373
Pediatr Emerg Care. 2018 Jan;34(1):47-52
pubmed: 29293201
Eur J Cancer. 2006 Sep;42(13):1981-2005
pubmed: 16919766
Cancer. 2020 Oct 1;126(19):4379-4389
pubmed: 32725630
J Pediatr Oncol Nurs. 2015 Nov-Dec;32(6):394-400
pubmed: 25643972
Value Health. 2013 Jun;16(4):647-54
pubmed: 23796300
BMJ Qual Improv Rep. 2017 Mar 7;6(1):
pubmed: 28321299
Pediatr Blood Cancer. 2013 Feb;60(2):262-9
pubmed: 22522576
Clin Transl Oncol. 2019 Dec;21(12):1687-1698
pubmed: 30937816
Int J Surg. 2021 Apr;88:105906
pubmed: 33789826
Value Health. 2013 Jun;16(4):639-46
pubmed: 23796299
Am J Infect Control. 2018 Feb;46(2):229-231
pubmed: 29031430
Klin Padiatr. 2018 Oct;230(6):314-318
pubmed: 30180265
Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):404-410.e1
pubmed: 27246140
Ann Oncol. 2012 Jul;23(7):1906-11
pubmed: 22317768

Auteurs

Sarah P Schladerer (SP)

Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.

Maria Otth (M)

Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
Pediatric Hematology-Oncology Center, Children's Hospital of Eastern Switzerland, St Gallen, Switzerland.
Department of Oncology, Hematology, Immunology, Stem Cell Transplantation and Somatic Gene Therapy, University Children's Hospital Zurich-Eleonore Foundation, Zurich, Switzerland.

Katrin Scheinemann (K)

Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
Pediatric Hematology-Oncology Center, Children's Hospital of Eastern Switzerland, St Gallen, Switzerland.
Department of Pediatrics, McMaster Children's Hospital and McMaster University, Hamilton, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH